ArticleGeburtshilfe und Frauenheilkunde2023

The Endocrine Treatment Landscape for Patients with HR+ HER2- Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy - A Real-World Analysis.

Naiba Nabieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.